Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Brain responses to gentle ear stimulation measured with near-infrared light

Official title: Neural Responses to Tactile Auricular Stimulation Measured by Functional Near-infrared Spectroscopy in Pain-free Volunteers

Run by University of Pittsburgh · NCT06825364 · Data updated 2026-11-12

This one-visit test uses gentle ear stimulation and near-infrared head sensors to see how healthy adults' brains respond.

More Healthy Male and Female Subjects trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedAugust 12, 2025
Main results expectedFebruary 1, 2028
Study endsFebruary 1, 2028
Registry record updatedFebruary 18, 2026
Trial IDNCT06825364 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are healthy adults (18+) without frequent or chronic pain, neuropathy, ear skin lesions, recent illicit drug use, recent opioid or marijuana use, substance misuse history, or regular psychoactive medications.

Probably not a fit

People with chronic or frequent pain, neuropathy, active ear skin problems, recent substance use, or regular psychoactive or opioid medication use are unlikely to participate or benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-visit, noninvasive experiment in healthy adult volunteers that records brain activity with functional near-infrared spectroscopy (fNIRS) while different points on both ears are gently stimulated. Investigators will stimulate auricular points linked to the shoulder, thumb, and lumbar spine using von Frey filaments and measure responses in the primary somatosensory cortex (S1) and prefrontal cortex (PFC). The hypothesis is that stimulation at different ear points will activate distinct areas within the S1 homunculus while producing similar PFC responses, supporting auricular cartography. Cortical responses will be localized and quantified across stimulation sites to compare patterns of activation.

Why it matters

Potential benefit: If successful, this could help validate ear-point mapping and guide more precise, noninvasive ear-based therapies or monitoring.

How similar studies have gone: fNIRS and auricular stimulation techniques have been used in prior research, but direct validation of detailed auricular cartography is relatively novel and not yet widely confirmed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age of at least 18 years

Exclusion Criteria:

1. frequent or chronic pain requiring the use of pain-relieving medications more than twice per week, on average, in the last 3 months,
2. history or symptoms of neuropathy,
3. active lesions or skin disruptions to either ear,
4. recent (\< 3 mo) illicit drug use,
5. history of substance misuse/abuse,
6. current or recent (\<1 month) opioid or marijuana use, and
7. current regular use of psychoactive prescription medications

Where it's running

  • University of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Keith Vogt, MD, PhD — University of Pittsburgh
  • Study coordinator: Carly Riedmann, MPH
  • Email: riedmannca@upmc.edu
  • Phone: 412-623-4147

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.